Wednesday, October 14, 2026

Can Artificial Intelligence Clean Up Healthcare Corruption? From Suspicion to Systemic Accountability

 


Can Artificial Intelligence Clean Up Healthcare Corruption? From Suspicion to Systemic Accountability

How AI could help India detect medical fraud, expose procurement irregularities, prevent insurance abuse and protect public money — provided the technology itself remains transparent and accountable.

Introduction: When Healthcare Corruption Becomes a Patient Safety Issue

Healthcare corruption is not merely a financial crime. It is a direct threat to human life.

When medicines are purchased at inflated prices, when substandard medical equipment enters hospitals, when insurance claims are raised for treatments that never occurred, or when public funds disappear through manipulated contracts, the consequences extend far beyond government accounts. Patients may face treatment delays, hospitals may experience shortages, and families may be forced to pay out of pocket for services that should have been available to them.

India's healthcare system operates at an enormous scale, involving government hospitals, private providers, pharmaceutical companies, insurers, Third-Party Administrators (TPAs), diagnostic centres and public health schemes. Every connection between these stakeholders creates an opportunity for efficiency — but also a potential vulnerability to fraud.

Recent allegations concerning medical procurement in Delhi have brought these vulnerabilities into focus. Investigations reported in 2026 have examined alleged irregularities in the purchase of medicines, surgical supplies and medical equipment worth hundreds of crores. These remain matters for investigation and due process, not a basis for presuming the guilt of every person or institution involved. Nevertheless, they raise an important question: could better technology have helped identify suspicious transactions earlier? Source: The Indian Express, September 2026.

Artificial intelligence (AI) offers a promising part of the answer.

AI cannot guarantee a corruption-free healthcare system. But it can make suspicious patterns harder to hide, financial transactions easier to trace, and oversight more continuous than traditional manual audits often allow.

The real opportunity is not to replace human accountability with algorithms. It is to build a healthcare system in which wrongdoing is more difficult to commit, easier to detect and harder to conceal.

1. Why Traditional Healthcare Oversight Is Not Enough

Healthcare corruption rarely occurs through a single transaction that immediately appears suspicious. It may develop through a chain of individually plausible decisions.

A supplier may quote a slightly inflated price. A tender may contain restrictive specifications. A hospital may repeatedly purchase from the same vendor. A stock register may show medicines as received even when physical inventory tells a different story. An insurance claim may look legitimate until it is compared with hundreds of similar claims.

Traditional auditing is essential, but it often relies on sample checks, documentation reviews and investigations conducted after a problem has been reported. When records are fragmented across departments and institutions, connecting the dots becomes difficult.

Three structural weaknesses make this challenge particularly significant:

  • Fragmented data: Procurement, inventory, billing, insurance and patient records may sit in separate systems.

  • Delayed detection: Irregularities may only become visible months after payments have been made.

  • Limited audit capacity: Human auditors cannot manually examine every transaction in a large healthcare network in real time.

AI can help address these weaknesses by analysing large volumes of structured and unstructured data, identifying unusual patterns and directing investigators towards transactions that deserve closer scrutiny.

The distinction is important: AI does not automatically prove fraud. It helps identify where a closer examination may be necessary.

2. AI in Medical Procurement: Following the Money

Public procurement is one of the most promising areas for AI-enabled oversight.

Government healthcare institutions purchase medicines, surgical consumables, diagnostic equipment, hospital furniture, laboratory supplies and a wide range of services. Small pricing differences across thousands of transactions can add up to substantial expenditure.

An AI-enabled procurement monitoring system could analyse:

  • Prices paid by different hospitals for comparable products.

  • Differences between quoted prices and historical purchase prices.

  • Repeated awards to the same supplier or connected vendors.

  • Unusually short tender periods or suspicious bidding patterns.

  • Changes in quantities after a contract has been awarded.

  • Repeated emergency purchases that bypass ordinary planning.

  • Invoices that do not match purchase orders, delivery records or stock receipts.

For example, imagine that several hospitals purchase the same standard medical consumable. Most pay approximately ₹100 per unit, while one hospital repeatedly pays ₹180 to the same supplier.

That difference is not proof of corruption. Product specifications, quality, transport costs, taxes, contract terms and local supply conditions may explain it. But an AI system could flag the difference, compare the relevant records and send the transaction for review.

A more advanced system could connect tender documents, vendor ownership information, invoices, electronic delivery confirmations and payment records. It could then identify relationships that might be difficult to detect when each document is reviewed independently.

The objective is straightforward: move procurement oversight from occasional retrospective checking towards continuous risk-based monitoring.

However, the quality of the results depends on reliable data. If product descriptions are inconsistent, vendor identities are duplicated or procurement records are incomplete, the system may produce misleading alerts. AI must therefore be supported by standardised product codes, verified supplier records and a dependable digital audit trail.

3. AI and Health Insurance: Detecting Claims That Do Not Add Up

Insurance fraud creates another important opportunity for AI.

India's health insurance ecosystem includes private insurers, TPAs, hospitals and publicly funded programmes. Claims must be assessed for eligibility, documentation, medical necessity and compliance with applicable policy or scheme rules.

Potential irregularities can include duplicate billing, repeated claims for the same service, billing for services that were not provided, suspicious treatment patterns and inconsistencies between clinical documentation and claimed procedures.

AI can screen claims for patterns such as:

  • Multiple claims that appear to relate to the same treatment episode.

  • Unusually high volumes of particular procedures at a facility.

  • Repeated billing patterns that differ significantly from comparable providers.

  • Inconsistencies between discharge summaries, procedure records and invoices.

  • Potentially altered, duplicated or fabricated supporting documents.

  • Unexpected relationships between providers, patients and billing entities.

This is especially valuable when claims are processed at scale. A human reviewer may struggle to identify a pattern spread across thousands of records, while an appropriately designed analytical system can compare them rapidly.

India is already exploring this direction. In May 2026, the National Health Authority, working with the IndiaAI Mission and the Indian Institute of Science, showcased solutions developed through the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) Auto-Adjudication Hackathon. The initiative included AI-based clinical document analysis and forgery or deepfake detection, with an emphasis on improving transparency and claims integrity. This is an encouraging step towards AI-assisted oversight, although a hackathon showcase should not be mistaken for proof that every solution has been deployed nationwide or has already reduced fraud. Source: Press Information Bureau, 9 May 2026.

The policy implication is significant. Rather than relying exclusively on random audits or complaints, health schemes could use AI to prioritise claims for review according to risk.

But a high-risk score must not become an automatic declaration of guilt. A complex but legitimate case can look unusual. A hospital treating a large number of seriously ill patients may naturally have a different claims profile from a smaller facility.

AI should help investigators ask better questions — not make unchallengeable decisions about patients or providers.

4. Can AI Help Detect Ghost Patients and Unnecessary Procedures?

A further challenge involves services that may have been billed but not genuinely delivered.

In some healthcare fraud scenarios, claims may be submitted for non-existent patients, duplicated patient identities, treatments that were not performed or services that were not medically justified. AI can help identify patterns across patient registration, admission, procedure, pharmacy and discharge records.

For example, a system could flag repeated use of the same patient identifier across incompatible admissions, unusual clusters of claims, or billing records that do not align with the documented treatment timeline.

Where appropriate, these signals could be cross-checked against authenticated records and independently verified evidence.

Yet this area requires particular care. Medical records contain sensitive personal information, and unusual treatment patterns can have legitimate explanations. A patient may seek care at multiple hospitals, and a complicated illness may involve several procedures or specialists.

Any use of AI to detect suspicious treatment activity must therefore include strict privacy protections, access controls and a process for correcting inaccurate records. Data should be used only for legitimate, clearly defined purposes.

The goal must be to protect patients and public funds — not to create a system in which patients are treated as suspects because an algorithm cannot understand their circumstances.

5. Medicine Stock Management: Reducing Leakage and Shortages

Corruption is not always visible as an inflated invoice. It can also appear as a gap between what a hospital purchases, what it receives and what it actually has available for patients.

AI-enabled inventory systems could compare procurement orders with delivery records, batch numbers, expiry dates, dispensing logs and physical stock verification.

Such systems could flag:

  • Stock levels that are inconsistent with recorded purchases and consumption.

  • Repeated shortages despite apparently adequate supplies.

  • Unexplained losses of high-value medicines.

  • Unusually high wastage or expiry rates.

  • Sudden changes in consumption that require verification.

  • Repeated discrepancies between electronic records and physical counts.

Predictive analytics can also forecast demand and help hospitals order appropriate quantities. Better forecasting may reduce emergency purchases, overstocking and avoidable medicine expiry.

This creates a useful connection between operational efficiency and anti-corruption efforts. A hospital that knows what it ordered, what arrived, where it was stored and when it was dispensed has a stronger basis for detecting discrepancies.

Still, a digital inventory record is not the same as a verified physical stock. If a person enters false information into the system, AI may analyse that information very efficiently without discovering the underlying deception. Periodic physical verification, supplier confirmation and clear responsibility for stock handling remain essential.

6. The TPA Opportunity: Moving from Claims Processing to Intelligent Oversight

Third-Party Administrators have an important role in the health insurance ecosystem. They commonly support activities such as cashless authorisation, claims processing, documentation review and coordination between hospitals and insurers, depending on their contractual responsibilities.

AI could help TPAs and insurers identify unusual billing patterns, duplicate documentation, inconsistent coding and claims that warrant medical audit.

For example, an AI system could compare a hospital's claims profile with its own historical data and with appropriately adjusted peer benchmarks. If the frequency or cost of a particular procedure rises sharply, the system could flag the change for review.

It could also help organise large volumes of medical documents, identify missing records and direct complex claims to appropriately qualified reviewers.

However, the incentives matter. If an AI system is designed primarily to reject expensive claims or reduce payouts, it could unfairly disadvantage patients with complex conditions. Likewise, if hospitals or insurers can influence the model without independent oversight, the system could reinforce existing conflicts of interest.

A responsible framework should require clear rules for claim review, documented reasons for adverse decisions, human reconsideration and a meaningful appeal mechanism.

The objective should be to detect fraudulent claims without making legitimate healthcare harder to access.

7. The Biggest Risk: What If AI Becomes Another Tool for Corruption?

It would be a mistake to assume that technology automatically creates transparency.

AI systems are developed, purchased, configured and operated by people and organisations. If those processes are not transparent, the technology may introduce new risks.

Consider four possibilities.

First, manipulated data. If procurement records are deliberately falsified, an AI system may produce misleading conclusions.

Second, biased algorithms. If historical data contains unfair patterns, the model may disproportionately flag certain hospitals or providers without sufficient justification.

Third, opaque decisions. If officials cannot explain why a transaction was flagged or cleared, it becomes difficult to challenge errors or assign responsibility.

Fourth, conflicts of interest. If the organisation being monitored controls the system's data, settings or audit access, it may be able to weaken the very oversight the technology is meant to provide.

There is also a danger that AI could be used to create the appearance of compliance: dashboards may look sophisticated while key records remain missing, exceptions go unexplained and audit findings lead to no action.

For these reasons, AI systems used in public healthcare must themselves be auditable. Their performance should be tested, access to sensitive data controlled, material changes documented and significant decisions subject to human review.

India's governance approach recognises the importance of responsible and trusted AI. The India AI Governance Guidelines emphasise balancing innovation with safety, accountability and inclusion. These principles are relevant not only to clinical AI but also to systems used for procurement, insurance and public administration. Source: Press Information Bureaucracy, February 2026.

8. What India Should Do Next

If India wants AI to become a credible tool against healthcare corruption, implementation should focus on governance rather than technology alone.

1. Build an integrated, traceable procurement system

Standardise product descriptions, supplier identities, tender records, purchase orders, delivery confirmations, invoices and payments. Link these records wherever legally and operationally appropriate.

2. Establish continuous risk-based audits

Use AI to identify unusual prices, repeated vendor concentration, duplicate payments and unexplained stock discrepancies. Every alert should have a defined review process and a recorded outcome.

3. Keep an independent human decision-maker in the loop

AI should flag risks and organise evidence. Authorised professionals should investigate, consider explanations and make consequential decisions in accordance with the law.

4. Create public transparency without compromising privacy

Publish appropriate procurement information, contract awards, aggregate spending, audit findings and action-taken reports. Patient-identifiable information and legitimate confidential data must remain protected.

5. Audit the AI system itself

Independently assess accuracy, false positives, missed cases, bias, security and the possibility of manipulation. Maintain records of who changed the system, why it was changed and how those changes affected results.

6. Protect whistle-blowers and strengthen accountability

Technology cannot replace people who report wrongdoing. Staff, suppliers and healthcare professionals need safe, credible channels to raise concerns, along with fair procedures for investigating them.

7. Measure results, not software adoption

Success should be judged by outcomes: fewer unexplained price differences, more accurate inventory, shorter investigation delays, better recovery of misused funds, fairer claims processing and improved availability of medicines and services.

The most important performance indicator is not how many transactions an AI system flags. It is how effectively the healthcare system verifies those alerts, corrects genuine problems and prevents recurrence.

Conclusion: AI Can Illuminate the System, but People Must Act

Can artificial intelligence clear corruption from healthcare?

Not by itself.

AI cannot replace ethical leadership, honest procurement officers, competent auditors, independent investigators or a justice system that acts on credible evidence. Nor can it guarantee that the information fed into a digital system is truthful.

What it can do is make large and complicated healthcare systems more observable. It can compare transactions that would otherwise remain disconnected, identify unusual patterns earlier, strengthen documentation and help oversight teams focus their limited resources where they may matter most.

For India, the opportunity is especially important because public healthcare spending must translate into medicines, equipment, treatment and better patient outcomes. Every rupee diverted through proven fraud is a rupee that cannot serve its intended purpose.

The path forward is therefore not simply to introduce AI into hospitals and government departments. It is to combine reliable digital records, intelligent risk detection, independent audits, transparent procurement, privacy safeguards and enforceable accountability.

AI may not eliminate corruption, but it can help build a system in which corruption is harder to conceal and public money is easier to trace.

Ultimately, the success of AI in healthcare will not be measured by the sophistication of its algorithms. It will be measured by whether patients receive the care they need, hospitals receive the supplies they were promised, and public money reaches the purpose for which it was allocated.


Corruption in Healthcare: What Recent Events in Delhi Reveal About Governance, Public Money and Patient Welfare

 


Corruption in Healthcare: What Recent Events in Delhi Reveal About Governance, Public Money and Patient Welfare

A healthcare economics perspective on procurement irregularities, accountability and the human cost of corruption


Introduction: When corruption enters the healthcare system, patients pay the price

Healthcare corruption is often discussed in terms of money lost, officials investigated or contracts allegedly manipulated. But these measures tell only part of the story.

When public money intended for hospitals is allegedly lost through inflated procurement prices, the consequences can extend far beyond government accounts. Hospitals may receive fewer supplies for the same budget. Equipment investments may deliver less value. Administrative failures can undermine service delivery, and patients may ultimately bear the cost through delayed treatment, unavailable medicines or reduced confidence in public institutions.

Recent developments in Delhi have brought these questions into sharp focus.

In 2026, the Delhi government's health procurement system became the subject of a major Anti-Corruption Branch investigation involving alleged irregularities in the purchase of medicines, surgical supplies and medical equipment. Separately, allegations concerning hospital construction projects, concerns about staffing and a reported disappearance of expensive cancer medicines have highlighted different dimensions of governance in public healthcare.

These matters are not all the same, and they should not be treated as proof of one common conspiracy. Some involve criminal allegations under investigation, others concern administrative or judicial scrutiny, and some raise operational concerns that are not, by themselves, evidence of corruption.

Nevertheless, together they raise an important question for healthcare leaders and policymakers:

How can a healthcare system protect public money while ensuring that every rupee allocated to patient care delivers genuine clinical and social value?

The answer requires more than arrests, inquiries or changes in government. It requires transparent procurement, strong internal controls, independent oversight and a governance model that treats patient welfare as the ultimate measure of public expenditure.

1. Delhi's alleged medical procurement scam: Understanding the economics

One of the most significant recent cases concerns alleged irregularities in procurement through the Central Procurement Agency (CPA), which supplies medicines, surgical items and medical equipment to Delhi government healthcare facilities.

According to reporting by The Indian Express and India Today in June 2026, the Anti-Corruption Branch registered a case following allegations that procurement prices were substantially inflated and that tender processes had been manipulated to favour selected suppliers.

The reported allegations included discrepancies involving portable X-ray machines, C-arm equipment, hospital linen, oral rehydration salts and surgical supplies. The reported estimates of potential losses and the overall scale of the case have varied across accounts. The investigation, rather than a final judicial determination, must establish the facts.

Sources:

Why does procurement matter so much in healthcare?

Procurement is not merely an administrative activity. It is one of the most important financial functions in a healthcare organisation.

Hospitals require medicines, diagnostic equipment, surgical instruments, consumables, linen, laboratory supplies and maintenance services. Every procurement decision affects the cost, availability and quality of healthcare delivery.

Consider a simplified illustration.

A government hospital has a budget of ₹10 crore for medical equipment. If the hospital can obtain equipment that meets the required clinical specifications at competitive prices, the budget may support a larger number of departments or facilities.

If the same equipment is purchased at unjustifiably inflated prices, the hospital may receive fewer units for the same expenditure.

The result is an opportunity cost: money spent inefficiently cannot simultaneously be used to meet other healthcare needs.

This does not mean the cheapest product is always the best purchase. Medical equipment must be assessed on quality, safety, warranty, maintenance, compatibility, training and lifecycle costs.

The objective is the best defensible value for public money, not simply the lowest purchase price.

What makes alleged procurement manipulation particularly damaging?

If an investigation establishes that prices were deliberately inflated, tender conditions manipulated or payments improperly approved, the damage can occur at several levels:

  • Public funds may be diverted from their intended purpose.

  • Competitive suppliers may be excluded.

  • Hospitals may receive fewer supplies than their budgets should support.

  • Equipment quality and maintenance may receive insufficient attention.

  • Public officials and legitimate suppliers may lose confidence in procurement systems.

The economic harm is not limited to the alleged financial loss. It also includes the value of healthcare services that the same money could otherwise have supported.

2. The human cost: Public money is ultimately meant for patients

It is easy to discuss an alleged procurement irregularity as a financial dispute between government departments and suppliers.

Healthcare economics demands a different perspective.

The real question is what that expenditure was intended to achieve.

A portable X-ray machine is meant to support diagnosis. Surgical supplies are intended to enable safe procedures. Medicines are necessary for treatment. Hospital beds and linen contribute to the functioning of clinical services.

When procurement systems fail, the immediate financial loss may be measurable, but the full patient impact can be more difficult to quantify.

For example, a hospital that cannot obtain sufficient equipment may have to redirect patients, delay certain investigations or rely on alternative facilities. Whether those outcomes actually occurred in a particular case must be established using hospital-level evidence rather than assumed from the existence of an investigation.

The broader principle, however, is clear: procurement governance and clinical outcomes are closely connected.

A healthcare budget should therefore be evaluated using two complementary measures:

  1. Financial integrity: Was the money spent lawfully, transparently and at a defensible price?

  2. Clinical value: Did the expenditure deliver the required healthcare capacity, quality and patient benefit?

A system that examines only the first measure may overlook whether equipment is actually used. A system that examines only the second may overlook waste, inflated costs or improper conduct.

Both matter.

3. What happened after the allegations emerged?

The response to Delhi's procurement case also offers an important lesson about the design of public healthcare administration.

In August 2026, The Indian Express reported that Delhi's Health Department had temporarily put centralised procurement through the CPA on hold for most categories covered by the order, allowing individual government hospitals to undertake specified purchases under the applicable rules. Existing arrangements were subject to the conditions outlined in the order.

The stated purpose included maintaining the uninterrupted availability of essential healthcare supplies while procurement arrangements were reviewed.

Source: The Indian Express, August 7, 2026.

This development highlights a difficult administrative trade-off.

Centralised procurement can aggregate demand, improve bargaining power, standardise specifications and reduce duplicated purchasing work. It can also concentrate decision-making and create a large point of vulnerability if controls fail.

Decentralised procurement can allow hospitals to respond to local needs and make certain purchases more quickly. However, it can also fragment demand, reduce negotiating leverage and make oversight more complicated if many institutions use different processes.

Neither model is inherently immune to corruption.

The appropriate question is not simply whether procurement should be centralised or decentralised. It is how the system should distribute authority, verify prices, document decisions and detect irregularities before significant public funds are committed.

A robust model may combine centralised price discovery and common technical standards with clearly defined local purchasing authority, subject to transparent rules and independent audit.

4. Accountability: Investigations must establish responsibility, not merely generate headlines

By September 30, 2026, The Indian Express reported that the Delhi government had sanctioned prosecution of three former officials in connection with the alleged procurement scam. The report also described allegations concerning tendering, supplier relationships and the processing of payments.

The same date, separate reporting by the newspaper said a court had flagged investigative lapses, including concerns about entries in a case diary and undated statements.

Sources:

These developments must be read together.

Sanction for prosecution is a significant procedural step, but it is not a conviction. Arrest, an FIR or a chargesheet does not by itself establish guilt. Equally, concerns about the quality of an investigation do not automatically disprove the underlying allegations.

A credible anti-corruption framework must allow allegations to be investigated thoroughly, evidence to be tested and responsibility to be established through due process.

Why does this matter economically?

Because weak accountability has two costs.

First, failure to investigate genuine misconduct can allow waste and improper practices to continue. Second, poorly conducted investigations can undermine legitimate enforcement, damage reputations unfairly and make it harder to establish the truth.

The objective should be reliable accountability, not simply visible action.

For healthcare institutions, this means clearly defined responsibilities, documented approvals, audit trails, independent review and consequences based on established findings.

5. Hospital construction controversies: The opportunity cost of unfinished infrastructure

The procurement investigation is not the only issue that has raised questions about healthcare governance in Delhi.

In June 2025, the Anti-Corruption Branch registered an FIR concerning alleged irregularities and delays in government hospital, polyclinic and intensive care infrastructure projects. The case involved projects sanctioned under earlier administrations, and former health ministers were named in the reported FIR.

The allegations included cost escalations, missed deadlines and questions about the implementation of planned healthcare facilities. The accused and their political representatives disputed aspects of the allegations. The registration of the FIR should not be interpreted as proof that the named individuals committed an offence.

Source: The Indian Express, June 26, 2025.

From a healthcare economics perspective, the most important issue is the value of infrastructure investment.

A hospital project does not create full healthcare capacity simply because money has been spent on construction.

It must be completed, equipped, staffed, supplied and integrated into the healthcare network. A building without adequate clinical personnel or functional equipment cannot provide the intended level of care.

The economics of delayed projects

Delays can generate several types of cost:

  • Escalation in construction and material costs.

  • Additional financing and administrative expenditure.

  • Deferred access to planned medical services.

  • Potential deterioration or underutilisation of completed assets.

  • Lost opportunities to reduce pressure on existing hospitals.

The extent of these costs varies by project and requires documentary evidence.

Nevertheless, one principle should guide public infrastructure investment: expenditure incurred is not the same as public value delivered.

A project should be monitored from sanction through design, construction, commissioning, staffing and actual service delivery. Milestones should be independently verified, and changes in cost or timelines should require documented justification.

6. The reported disappearance of cancer medicines: A different but related governance question

A separate report published by The Indian Express on October 14, 2026, said that four vials of nimotuzumab, a costly medicine used in certain cancer treatments, had reportedly gone missing from the Delhi State Cancer Institute. The report also referred to a missing hepatitis C medicine and stated that a police investigation was underway.

Source: The Indian Express, October 14, 2026: Cancer medicines reported missing from Delhi hospital.

At the time of that report, the circumstances and responsibility had not been established. A reported loss of medicines is not, by itself, proof of corruption or organised theft.

Nevertheless, the incident raises an important governance question: how should hospitals control high-value and clinically essential medicines?

Medicines require more than a purchasing system. They also require secure receipt, appropriate storage, inventory reconciliation, authorised dispensing, documentation and monitoring of stock movements.

For high-value medicines, practical controls can include:

  • Batch-level inventory records.

  • Restricted access to storage facilities.

  • Electronic recording of receipt and dispensing.

  • Regular reconciliation of physical and recorded stock.

  • Documented investigation of discrepancies.

  • Clear separation of ordering, receiving and stock-approval responsibilities.

Such controls protect public resources while helping ensure that medicines remain available to patients who need them.

The objective is not to assume wrongdoing whenever a discrepancy occurs. It is to ensure that every discrepancy can be explained, investigated and resolved through a reliable process.

7. Corruption versus administrative failure: Why the distinction matters

Not every healthcare failure is corruption.

A hospital may experience delays because of poor planning, inadequate staffing, weak coordination, insufficient funding, technical problems or slow approvals. Corruption involves a different set of concerns, such as bribery, dishonest manipulation, improper personal benefit or other unlawful conduct, depending on the evidence and applicable law.

These problems can overlap, but they should not be treated as interchangeable.

For example:

  • A delayed procurement process may indicate administrative inefficiency; evidence of deliberate favouritism or bribery would require a separate assessment.

  • A missing medicine may reflect an inventory error, a documentation failure or theft. Investigation is needed to establish what happened.

  • An incomplete hospital project may result from contractual disputes, planning failures, inadequate execution or alleged misconduct.

  • A high purchase price may reflect specialised specifications or lifecycle costs, or it may indicate an unjustified premium. A proper comparison requires like-for-like evidence.

This distinction is essential for two reasons.

First, it prevents public debate from turning unverified allegations into established facts. Second, it allows governments and healthcare organisations to address the actual cause of a failure rather than relying on a single response to every problem.

Anti-corruption enforcement is necessary where wrongdoing is suspected. Better management, stronger controls and more capable institutions are equally necessary to prevent failures that arise from other causes.

8. The systemic vulnerabilities that healthcare procurement must address

The Delhi cases raise questions that are relevant well beyond one city or administration.

A. Tender design and competition

Specifications should be based on genuine clinical requirements. Unnecessarily restrictive criteria can reduce competition, while poorly designed tenders may result in unsuitable products or weak service support.

Tender documents should clearly state technical requirements, evaluation criteria, delivery obligations and maintenance responsibilities.

B. Price benchmarking

Public buyers need reliable comparisons with equivalent products and services. Comparisons should account for specifications, quantities, warranties, delivery terms, maintenance and other relevant costs.

Large price differences should trigger documented scrutiny, not automatic conclusions of wrongdoing.

C. Separation of responsibilities

No single individual should exercise unchecked control over the entire procurement process.

Requesting a product, defining specifications, evaluating bids, approving expenditure, receiving supplies and authorising payment should involve appropriate checks and independent verification.

D. Supplier due diligence

Buyers should verify supplier credentials, beneficial ownership where required, technical capacity, financial standing, conflicts of interest and performance history.

Appropriate due diligence helps reduce the risk of collusion, non-performance and conflicts of interest.

E. Contract and delivery verification

The purchase order is only one stage of procurement. Hospitals must verify that the correct quantity and quality of supplies have been delivered and that equipment performs as specified.

Payment approval should follow the applicable verification and acceptance procedures.

F. Independent audit and whistle-blower protection

Internal controls should be supplemented by independent financial and technical audits. Employees who identify irregularities need credible reporting channels and protection against retaliation under applicable law and policy.

These measures can help identify weaknesses before they become major financial or operational failures.

9. What should Delhi—and India—do differently?

A meaningful response should go beyond suspending a procurement process or investigating individual officials. It should strengthen the systems that govern healthcare expenditure.

1. Build a transparent procurement dashboard

For major public healthcare purchases, governments should publish appropriate information on tender specifications, bidders, award values, delivery milestones and contract performance, subject to lawful confidentiality and security restrictions.

Transparency makes it easier for auditors, suppliers, researchers and citizens to identify unusual patterns.

2. Use independent price and technical verification

Large or high-risk purchases should undergo independent scrutiny of technical specifications, comparable market prices and total lifecycle costs.

The review should be proportionate to the size, complexity and risk of the purchase.

3. Create end-to-end digital audit trails

Every major decision—from requisition and tender evaluation to delivery and payment—should be traceable.

Digital systems cannot eliminate collusion on their own, but they can make undocumented changes and unexplained approvals more difficult to conceal.

4. Measure whether purchased assets actually improve care

Governments should track not only procurement expenditure but also equipment installation, uptime, utilisation, maintenance, availability of trained operators and the services delivered.

A machine that has been purchased but remains unusable represents a different kind of value failure from an inflated purchase price. Both deserve attention.

5. Strengthen inventory management

Hospitals should maintain reliable records for medicines, surgical supplies and high-value equipment, with risk-based physical verification and documented resolution of discrepancies.

6. Protect continuity of healthcare services

When procurement arrangements are suspended or restructured, governments must ensure that essential medicines and supplies remain available.

Reforms should be designed so that the effort to improve accountability does not unintentionally disrupt patient care.

7. Make responsibility measurable

Senior administrators, procurement officers, technical evaluators, finance personnel and contractors should have clearly defined duties.

Accountability should be based on documented responsibilities, evidence and due process—not merely the seniority or political position of an individual.

8. Publish corrective actions and follow-up outcomes

After an audit or investigation identifies a weakness, institutions should document the corrective action, responsible authority, implementation timeline and subsequent verification.

The public interest is served when investigations lead to stronger systems as well as appropriate legal consequences where misconduct is established.

10. A healthcare economics framework for measuring corruption risk

Healthcare institutions often measure budgets, expenditure, procurement savings and service volumes. They should also assess the risks that threaten the value of those expenditures.

A useful framework can combine financial, operational and clinical indicators.

DimensionWhat should be measured?
Procurement integrityCompetition, price deviations, justified exceptions and compliance with tender rules
Financial controlAudit observations, unexplained payments and timely reconciliation
Delivery performanceOn-time delivery, specification compliance and verified acceptance
Asset utilisationEquipment uptime, utilisation and maintenance performance
Medicine availabilityStock-outs, inventory discrepancies and expiry-related losses
Patient impactTreatment delays, service interruptions and relevant clinical outcomes
AccountabilityCorrective actions completed and independently verified

These indicators should be interpreted in context. A high number of audit observations may reflect stronger detection rather than worse underlying performance, while a low number may reflect inadequate scrutiny.

The purpose of the framework is to identify risks, improve decision-making and establish whether corrective actions work—not to create a simplistic league table of hospitals or governments.

Conclusion: The real cost of healthcare corruption is the care that public money fails to deliver

Recent developments in Delhi have highlighted serious questions about medical procurement, public infrastructure, inventory control and institutional accountability.

The alleged procurement fraud requires a fair and thorough investigation. The reported medicine disappearance requires the facts to be established. Questions about hospital projects and service delivery deserve scrutiny through reliable records and independent assessment.

None of these cases should be prejudged. Equally, they should not be dismissed as merely political controversies when they concern resources intended for public healthcare.

The broader lesson is that healthcare governance must be designed around the protection of public value.

Every rupee allocated to a government hospital has an intended purpose: to provide medicines, diagnostic capacity, trained personnel, safe infrastructure and effective treatment. When expenditure fails to deliver those outcomes, whether through alleged corruption, weak controls or administrative failure, the public loses more than money.

It loses potential healthcare capacity.

India needs transparent procurement, competent administration, independent oversight, reliable inventory systems and accountability grounded in evidence. It also needs to measure public expenditure by what hospitals can actually deliver to patients.

The ultimate test of healthcare governance is not how much money is sanctioned, how many contracts are awarded or how many investigations are announced. It is whether public resources are converted into accessible, safe and effective healthcare—and whether every allegation of wrongdoing is examined fairly and responsibly.

That is how trust in public healthcare can be strengthened: not through slogans, but through systems that protect public money, uphold due process and put patients first.


The Role of TPAs in Health Insurance in India: The Bridge Between Patients, Hospitals and Insurers

 

The Role of TPAs in Health Insurance in India: The Bridge Between Patients, Hospitals and Insurers

Understanding how Third-Party Administrators influence claims, hospital operations, patient experience and the economics of healthcare


Introduction: The invisible link in healthcare financing

When a patient is admitted to a hospital, the immediate concerns are diagnosis, treatment, recovery and the cost of care. For an insured patient, another process begins in parallel: eligibility verification, cashless treatment authorisation, medical documentation, claim assessment and settlement.

Behind much of this administrative process may be an organisation that the patient rarely encounters before a medical emergency—the Third-Party Administrator, commonly known as a TPA.

In India's health insurance ecosystem, TPAs help connect insurance companies, hospitals and policyholders. They perform important administrative and claims-related functions that can influence how smoothly a patient moves through the insurance process.

Yet their role is frequently misunderstood. Some patients assume that a TPA is the insurance company itself. Others believe that every claim decision rests entirely with the TPA. In reality, the division of responsibilities depends on the applicable regulations, the insurer's arrangements and the particular claim.

The central question is: How can TPAs make healthcare financing more efficient while ensuring that patients receive fair, timely and transparent service?

Answering this question requires looking beyond claims processing to understand the broader economics of healthcare delivery.

1. What is a Third-Party Administrator?

A Third-Party Administrator is an organisation registered with the Insurance Regulatory and Development Authority of India (IRDAI) to provide specified health-related administrative services to insurers under applicable regulations.

The regulatory framework governing TPAs includes the IRDAI (Third Party Administrators–Health Services) Regulations, 2016, as amended. These regulations describe the health services a TPA may provide to an insurer, including cashless pre-authorisation and the servicing of eligible non-cashless claims. Official regulatory reference.

In simple terms, a TPA helps administer the health insurance process.

It may coordinate documents, verify policy information, communicate with hospitals, process claim information and facilitate the applicable authorisation or settlement workflow.

However, a TPA is not automatically the entity that bears the insurance risk. Under a conventional insured health policy, that responsibility rests with the insurer. The insurer's contractual obligations and regulatory responsibilities remain important even when claims administration is outsourced.

A TPA should therefore be understood as an administrative and service partner within the insurance ecosystem, rather than as a substitute for the insurer.

2. Why does the health insurance industry need TPAs?

Health insurance involves multiple parties and a large volume of information.

An insurer may cover policyholders across many cities, states and hospital networks. Each hospital generates clinical records, treatment estimates, bills and discharge summaries. Claims must be assessed against policy terms, benefit limits, exclusions and applicable procedures.

Managing these activities requires trained personnel, technology, standardised workflows and coordination between institutions.

TPAs can help insurers manage these operational requirements by providing specialised administrative capabilities.

Their role can be particularly valuable in the following areas:

  • Processing large volumes of hospitalisation-related documentation.

  • Coordinating cashless treatment requests.

  • Communicating with hospital insurance desks.

  • Supporting reimbursement claim administration.

  • Maintaining records and claim-related information.

  • Helping policyholders navigate specified insurance service processes.

From a business perspective, this arrangement allows insurers to use external administrative expertise instead of building every operational function internally.

However, outsourcing does not automatically guarantee efficiency. The value of a TPA depends on its service quality, technological capability, staffing, governance and ability to resolve issues promptly.

The objective should be to reduce administrative friction without creating another layer of complexity for patients or hospitals.

3. How does a TPA work? Understanding the patient journey

Consider a patient who has a health insurance policy and requires hospitalisation for a covered medical condition.

The process typically involves several stages, although the precise workflow differs across insurers, products, hospitals and claim types.

Step 1: Hospital admission and insurance verification

The patient or family informs the hospital that health insurance is available. The hospital's insurance desk collects the required policy and identification information and checks whether the facility participates in the relevant insurer's cashless network.

The TPA or insurer may then be contacted through the applicable process.

Step 2: Submission of the cashless request

The hospital submits the pre-authorisation request, including relevant medical information, the proposed treatment and the estimated cost.

The request is assessed against the policy terms and the applicable authorisation framework.

Step 3: Review and communication

The TPA may coordinate the review and seek clarification or additional documentation where required. Depending on the insurer's arrangements and the nature of the decision, the insurer may also be involved directly.

The request may be authorised, authorised subject to conditions, kept pending for further information or declined with applicable reasons.

An initial authorisation is not necessarily a guarantee that every final billed amount will be payable. The final assessment remains subject to the policy and applicable claim procedures.

Step 4: Treatment and additional requests

If the clinical situation changes or the estimated cost increases, the hospital may need to submit updated information or seek an enhancement of the authorised amount.

Timely communication matters because delays or uncertainty can create stress for the patient and additional work for hospital staff.

Step 5: Final bill and discharge

At discharge, the hospital submits the final bill and required clinical documentation through the applicable workflow.

Covered expenses are processed under the relevant policy terms and authorisation. Any legitimate non-payable amount, deductible, co-payment or other applicable patient liability should be communicated clearly.

Step 6: Claim closure and settlement

For cashless claims, payment is generally made by the insurer to the hospital according to the applicable arrangements. For reimbursement claims, the patient may first pay the hospital and then submit the claim through the insurer's or TPA's designated process.

The responsible parties assess the claim under the relevant policy terms and procedures. A TPA's involvement does not remove the insurer's contractual responsibilities.

The real purpose of this process is to coordinate treatment financing efficiently—not to make the patient navigate multiple institutions during a medical emergency.

4. The major functions of a TPA

A. Cashless pre-authorisation

One of the most visible functions of a TPA is coordinating the cashless treatment process.

Cashless treatment can reduce the need for patients to arrange the entire hospital bill upfront, subject to policy conditions and the applicable authorisation.

The TPA's efficiency can influence how quickly information is exchanged between the hospital and the relevant insurance decision-maker.

Incomplete documents, unclear medical information and repeated requests for clarification can slow the process. Standardised forms, digital communication and clear escalation procedures can help reduce these problems.

B. Reimbursement claim administration

Not every hospitalisation takes place at a cashless-network facility, and not every policyholder uses cashless treatment.

In a reimbursement claim, the policyholder may need to pay the hospital first and then submit bills, prescriptions, diagnostic reports, discharge summaries and other required records.

A TPA may help process these documents and facilitate the applicable claim workflow.

For patients, clear guidance on documentation and timely updates are particularly important because reimbursement delays can create financial pressure after a medical emergency.

C. Hospital and provider coordination

Hospitals need clarity about network participation, authorisation requirements, documentation, applicable package arrangements and claim-related communication.

TPAs often act as an operational contact between hospital insurance desks and insurers.

Effective coordination can reduce repeated follow-ups, incomplete submissions and avoidable administrative work.

It can also help hospitals understand recurring reasons for claim queries and improve the quality of their documentation.

D. Policyholder assistance

Patients may need help understanding the status of a claim, the documents still required, the process for submitting a reimbursement request or the next step when a problem arises.

A TPA can provide assistance within its authorised service responsibilities.

However, the quality of assistance matters as much as its availability. Patients need explanations in clear language, accessible communication channels and a reliable way to escalate unresolved issues.

E. Data and administrative reporting

Claims generate valuable operational information.

When managed appropriately, this information can help identify common causes of processing delays, recurring documentation errors, utilisation patterns and administrative bottlenecks.

Such insights may support improvements in hospital workflows, insurer operations and claims governance.

The use of health and personal information must, of course, comply with applicable confidentiality, privacy and data-protection requirements.

5. TPAs and the economics of healthcare

The role of a TPA is not limited to administrative convenience. It also has implications for the financial performance of insurers and hospitals and for the experience of insured patients.

For insurance companies

TPAs can provide specialised operational capacity and help insurers manage claims workflows across multiple hospitals and locations.

Potential benefits include more standardised processing, better documentation management and improved operational visibility.

These benefits depend on effective contracts, appropriate oversight, robust technology and clear accountability.

For hospitals

Insurance-related administrative work requires staff, information systems and time.

When authorisation requests are processed efficiently and valid claims are settled predictably, hospitals may spend less time chasing documentation and managing unresolved billing queries.

Conversely, repeated queries, unclear decisions and delayed payments can increase administrative costs and put pressure on working capital.

For patients

The most important economic benefit is the possibility of receiving treatment with less financial and administrative stress.

A smooth cashless process can reduce the immediate need to arrange substantial funds. Clear reimbursement guidance can reduce errors and avoidable delays.

However, these benefits should not be confused with a guarantee that every treatment expense will be covered.

The patient's financial liability still depends on the policy, the covered service, applicable limits and the final claim assessment.

For the healthcare system

Efficient claims administration can reduce avoidable transaction costs and help healthcare financing operate more smoothly.

But administrative efficiency should not be measured only by the number of claims processed or the speed of closure. It must also be assessed through decision accuracy, fair treatment, transparency and the quality of the patient experience.

A fast but incorrect decision is not a successful outcome.

6. The challenges and limitations of the TPA model

Although TPAs can provide important services, their involvement does not eliminate the structural challenges of health insurance.

Delays in authorisation

Patients and hospitals may experience uncertainty when requests remain pending or additional documents are sought repeatedly.

Some delays may arise from incomplete submissions or complex clinical circumstances; others may reflect inefficient workflows or inadequate coordination.

The solution requires measuring the reasons for delay rather than assuming that every delay has the same cause.

Confusion about responsibility

Policyholders may not know whether to contact the hospital, TPA or insurer when a claim is disputed.

This confusion can lead to repeated calls, inconsistent explanations and frustration.

Insurers and TPAs should make the division of responsibilities clear and ensure that complaints reach the appropriate decision-maker without unnecessary transfers.

Disputes over coverage

A patient may expect a treatment to be covered but later discover that a particular expense is excluded, exceeds a policy limit or is subject to a specific condition.

The issue may involve policy wording, medical documentation, the interpretation of benefits or a disagreement over the bill.

TPAs must follow the applicable policy and delegated procedures. Insurers must remain accountable for their contractual obligations and the decisions they are responsible for making.

Patients should receive understandable explanations of relevant claim decisions and information about the available review and grievance processes.

Hospital billing and documentation issues

Claim queries do not always originate with the TPA. Missing documents, inconsistent codes, unclear bills or inadequate clinical justification can also create problems.

A well-designed process should identify the source of each issue and support corrective action rather than simply passing documents back and forth.

The risk of prioritising cost over patient service

Claims management must protect against errors, inappropriate billing and fraud. However, excessive administrative friction can delay legitimate care and increase the burden on patients and hospitals.

Performance measures should therefore balance cost control with accuracy, timeliness, fairness and patient satisfaction.

7. Does a TPA approve or reject every insurance claim?

This is an important distinction.

A TPA may process claims and undertake specified authorisation or assessment activities within the scope of its regulatory permissions, contractual agreement and the insurer's procedures.

However, the TPA is not the insurance company that issued the policy and does not automatically possess independent authority over every claim decision.

The precise allocation of functions depends on the applicable arrangements. The insurer remains responsible for its obligations under the insurance contract and applicable regulation.

For a policyholder, the practical implication is straightforward: if a claim is delayed, partly paid or declined, the patient should request the written explanation, identify the responsible insurer and follow the applicable grievance process.

A TPA's communication should not be treated as a substitute for understanding the policy terms or the insurer's responsibilities.

8. What makes an effective TPA?

A TPA's performance should be assessed through measurable service outcomes rather than the volume of transactions alone.

Important indicators include:

  • Authorisation turnaround time: How quickly complete requests receive a decision.

  • Claims-processing accuracy: How often claims are processed correctly without avoidable rework.

  • Query frequency: How often additional information is requested and why.

  • Reimbursement turnaround time: How efficiently complete reimbursement claims are handled within applicable requirements.

  • Hospital coordination: How effectively operational issues are resolved.

  • Complaint resolution: How promptly and transparently policyholder concerns are addressed.

  • Digital capability: Whether secure systems reduce repetitive work and improve status visibility.

  • Patient experience: Whether policyholders receive understandable information and respectful support.

These measures should be interpreted carefully. A low query rate is not necessarily good if legitimate issues are overlooked, and a fast decision is not useful if it is inaccurate.

Performance assessment should account for claim complexity, completeness of documentation and the different responsibilities of the hospital, TPA and insurer.

9. The future of TPAs: From claims administrators to healthcare service partners

India's health insurance ecosystem is becoming increasingly technology-driven. Digital hospital records, electronic claims submission, standardised data formats and workflow automation create opportunities to reduce manual work.

TPAs can contribute to this transition in several ways.

First, smarter document processing. Automated systems can help identify missing information and reduce repetitive data entry, subject to appropriate validation.

Second, greater transparency. Patients and hospitals should be able to track requests and understand whether a claim is awaiting documentation, review or a decision.

Third, better coordination. Secure connections between hospitals, TPAs and insurers can reduce duplicated submissions and inconsistent information.

Fourth, stronger analytical capability. Aggregated claims information may help identify recurring administrative bottlenecks and support process improvements.

Fifth, improved patient support. Multilingual assistance, clear explanations and accessible escalation channels can make insurance easier to navigate.

Technology must support, rather than replace, responsible decision-making. Sensitive medical information needs appropriate safeguards, and automated processes should be subject to oversight and correction.

The future of the TPA sector will depend on whether it can combine operational efficiency with trust, accountability and patient-centred service.

10. Recommendations for a stronger TPA ecosystem

To improve the effectiveness of TPAs in India, stakeholders should focus on a few practical priorities.

For insurers: Define responsibilities clearly, monitor service quality, provide reliable policy information and maintain effective oversight of outsourced activities.

For TPAs: Improve process transparency, invest in staff training, reduce avoidable documentation errors and provide clear explanations to patients and hospitals.

For hospitals: Submit complete and clinically appropriate documentation, communicate patient liabilities transparently and establish effective insurance-desk workflows.

For regulators: Maintain appropriate standards for registration, conduct, accountability and policyholder protection, while encouraging measurable improvements in service quality.

For policyholders: Understand the broad terms of their policy, retain relevant medical documents, request written explanations when a claim is disputed and contact the insurer when clarification or escalation is required.

The goal should be a system in which legitimate claims are handled efficiently, inappropriate claims are identified through fair processes and patients are not left confused about who is responsible for resolving a problem.

Conclusion: The true value of a TPA lies in the service it enables

Third-Party Administrators play an important operational role in India's health insurance ecosystem. They can help coordinate cashless treatment, process reimbursement claims, communicate with hospitals and support policyholders through complex administrative procedures.

Their contribution matters because insurance is not simply a financial product. It is a promise of financial protection that must function when people are vulnerable and need medical care.

Yet the presence of a TPA does not automatically guarantee cashless treatment, claim approval or high-quality healthcare. Those outcomes depend on the insurance contract, the insurer's responsibilities, the hospital's capacity, the quality of administration and the broader healthcare system.

The future of the sector should therefore be judged by more than the number of claims handled. It should be judged by the accuracy of decisions, the predictability of processes, the quality of communication and the reduction of unnecessary administrative and financial stress.

A successful TPA is not merely an organisation that processes claims. It is an organisation that helps make the health insurance system more accessible, efficient, transparent and dependable for the people it is designed to protect.


Insured, Yet Unprotected: Why Quality Healthcare Remains Out of Reach for Millions in India

 


Insured, Yet Unprotected: Why Quality Healthcare Remains Out of Reach for Millions in India

The gap between health insurance coverage and actual access to quality medical care

Introduction: The paradox of health insurance in India

Imagine a family that has a health insurance policy. The family has paid its premiums for years, or qualifies for a government-funded health scheme intended to protect it from major medical expenses. When a serious illness strikes, the family expects to receive timely treatment without exhausting its savings.

But reality can be very different.

The nearest hospital may not accept the insurance. The required specialist may be unavailable in the empanelled facility. A particular procedure may not fall within the policy's coverage. Medicines, diagnostic tests, transport and follow-up consultations may still require substantial out-of-pocket spending. Even when a hospital accepts the scheme, the quality and availability of care may vary.

The family is insured, but the treatment it needs remains difficult to obtain.

This is one of the most important problems facing India's healthcare system today: the difference between having financial coverage and having meaningful access to healthcare.

India has expanded public health assurance schemes, private insurance and hospital networks. These developments have helped many people obtain treatment and have reduced financial barriers for eligible beneficiaries. Yet insurance coverage alone cannot overcome every obstacle in a healthcare system where affordability, geography, infrastructure, staffing and quality remain interconnected challenges.

The central question is therefore not simply how many people have health insurance. It is whether an insured person can actually receive the right treatment, at the right time, at an appropriate facility, without facing financial hardship.

1. Insurance pays for covered healthcare; it does not create healthcare capacity

The first distinction we must understand is between financing healthcare and delivering healthcare.

Health insurance is primarily a financing mechanism. It helps pay for specified medical services according to the terms of a policy or government scheme. It does not automatically create hospitals, recruit specialists, establish diagnostic laboratories or ensure that medicines are available.

Consider a patient living in a remote district who needs urgent cardiac treatment. The patient may possess a valid insurance card, but if the nearest suitable hospital is several hours away, insurance alone cannot eliminate the geographical barrier.

Similarly, a patient may be eligible for a government health scheme but encounter a shortage of specialists, intensive care beds or advanced diagnostic equipment in the local network.

This reveals a fundamental economic principle: financial access is meaningful only when adequate healthcare services are physically available and clinically capable of meeting the patient's needs.

Expanding insurance without simultaneously strengthening healthcare infrastructure can leave a gap between the promise of coverage and the reality of treatment.

2. Government health schemes: Progress is important, but implementation matters

India's Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB PM-JAY) is designed to improve access to secondary and tertiary hospitalisation for eligible beneficiaries through cashless treatment at empanelled hospitals, subject to scheme rules.

The scheme represents an important attempt to reduce the financial burden of serious illness. However, the Comptroller and Auditor General of India examined its implementation in a performance audit covering September 2018 to March 2021. The audit identified issues involving beneficiary records, implementation, hospital participation and oversight that required attention. These findings should be understood in the context of the audit period rather than assumed to describe every hospital or the scheme's present performance. Source: CAG of India, Performance Audit of AB-PMJAY.

The policy lesson is not that government health insurance has failed. It is that a large-scale insurance programme must be supported by effective administration, sufficient provider capacity, reliable payment systems and strong accountability.

Four questions are particularly important:

  • Is the eligible patient able to establish their entitlement without unnecessary administrative difficulty?

  • Is an appropriate hospital available within a reasonable distance?

  • Does that hospital provide the treatment the patient actually needs?

  • Can the patient obtain the covered treatment without unexpected and unaffordable additional expenses?

A scheme may perform well on the number of cards issued or hospital admissions authorised while still facing challenges in some of these dimensions.

The success of public health insurance should therefore be assessed not only through coverage and utilisation figures, but also through timely access, treatment completion, patient experience, clinical quality and financial protection.

3. The hospital network problem: An empanelled hospital is not necessarily the right hospital

One of the most important barriers is the difference between the number of hospitals enrolled in a scheme and the actual availability of appropriate treatment.

A hospital may be empanelled for selected specialties or procedures but may not offer every service that a patient requires. It may lack a particular specialist, advanced equipment, critical care capacity or available beds at the time of need.

The problem becomes more pronounced when patients require complex or highly specialised treatment.

A person may have access to a general hospital but still need to travel to another city for cancer care, neurosurgery, advanced cardiac intervention or organ transplantation.

The Ministry of Health and Family Welfare's Annual Report 2024–25 highlighted hospital empanelment and the need to maintain and expand the participating network as important components of PM-JAY implementation. Source: Ministry of Health and Family Welfare.

The relevant measure is therefore not simply the total number of empanelled hospitals. It is the availability of the required specialty, the capacity to deliver the treatment, the distance from the patient and the hospital's actual participation in the scheme.

A more meaningful approach would map healthcare needs against local service capacity and identify districts where patients routinely have to travel long distances for essential treatment.

Insurance coverage without an accessible provider network is an incomplete form of financial protection.

4. Why private hospitals may not participate equally

Private hospitals are important providers of healthcare in India, but participation in publicly funded schemes involves economic considerations.

Hospitals must pay for doctors, nurses, medicines, consumables, equipment, utilities, maintenance and infrastructure. They must also manage administrative expenses and the time taken to receive reimbursement.

If the payment rate for a treatment does not adequately reflect the cost of delivering it at the required quality, a hospital may find participation financially difficult. The effect can be particularly significant for complex procedures, intensive care and facilities with high operating costs.

This does not mean that every hospital that declines a scheme is justified in doing so, or that every package rate is inadequate. Costs vary by location, institution, case complexity and the services included in a package.

It does mean that policymakers need reliable cost assessments and regular review of payment arrangements.

There is also a balance to be maintained. If reimbursement rates are too low, provider participation and service quality may suffer. If rates are too high or purchasing controls are weak, public funds may be used inefficiently and overall healthcare expenditure may rise.

The solution requires transparent pricing, evidence-based package rates, predictable claim settlement and monitoring of the quality of care delivered.

Public money should purchase appropriate, reliable healthcare—not merely an admission recorded in an administrative system.

5. The hidden gap: Insurance does not always cover the entire patient journey

Another reason insured patients continue to face financial hardship is that healthcare extends far beyond hospitalisation.

A typical patient journey may include:

  • Initial consultation and specialist assessment.

  • Laboratory tests and diagnostic imaging.

  • Medicines before treatment.

  • Hospital admission and surgery, if required.

  • Discharge medicines and rehabilitation.

  • Follow-up consultations and long-term monitoring.

Different insurance products cover different parts of this journey. Some government-funded hospitalisation schemes concentrate on eligible inpatient services. Many private health policies also have specific conditions, limits, exclusions and rules governing outpatient care, waiting periods, deductibles or co-payments.

Consequently, a patient may receive covered hospital treatment but still spend significant amounts on expenses that fall outside the applicable benefits.

For someone with diabetes, kidney disease, cancer or cardiovascular disease, repeated consultations, medicines, tests and ongoing monitoring may represent a substantial long-term financial burden.

The economic problem is especially important because outpatient services and medicines are recurring expenses. A policy that primarily protects against hospitalisation may not provide comprehensive protection against the everyday costs of managing illness.

India therefore needs a more integrated approach to financial protection, with careful attention to outpatient care, essential medicines, diagnostics, rehabilitation and continuity of treatment.

Expanding benefits should be accompanied by sound cost management and evidence-based decisions about which services provide the greatest health value.

6. Insurance eligibility is not the same as affordability

Even when a treatment is covered, patients can encounter indirect and residual costs.

These may include transportation, accommodation for family members, lost wages, food, caregiving and follow-up visits. In some situations, patients may also face expenses related to services or items not covered by their particular scheme or policy.

For a salaried household in a major city, these costs may be manageable. For a daily-wage worker or a family living in a remote village, the same expenses may become a major barrier.

This creates an important distinction between formal financial protection and effective financial protection.

A patient who cannot afford to travel to the hospital, take time away from work or purchase necessary uncovered medicines may delay or discontinue treatment despite being insured.

Healthcare policy must therefore consider the patient's total cost of obtaining care, rather than examining only the hospital bill reimbursed by an insurer.

A system that covers surgery but leaves a patient unable to complete the necessary follow-up treatment has not fully addressed the economic consequences of illness.

7. Quality is a separate challenge: Cashless treatment does not guarantee good treatment

There is another misconception that deserves attention: if treatment is cashless, the treatment must be good.

Financial coverage and clinical quality are separate dimensions.

Quality healthcare requires appropriately trained professionals, safe facilities, infection prevention, accurate diagnosis, evidence-based treatment, reliable medicines, respectful communication and continuity of care.

An insurance card cannot guarantee that all these conditions are present.

Quality may also vary between hospitals, departments and clinical teams. A facility may have the infrastructure to provide a procedure but still differ in its staffing, clinical governance, patient safety practices or outcomes.

This is why healthcare assurance programmes need robust standards and independent monitoring.

Quality assessment should include relevant indicators such as surgical complications, hospital-acquired infections, unplanned readmissions, treatment delays, mortality adjusted for case severity where appropriate, patient experience and adherence to clinical protocols.

The emphasis should be on meaningful outcomes rather than paperwork alone.

Patients should not have to choose between a treatment they can afford and a treatment that meets appropriate standards of quality.

8. Administrative complexity can turn a healthcare entitlement into a practical obstacle

Healthcare systems frequently require identity verification, eligibility checks, pre-authorisation, documentation, coding and claims processing.

These procedures serve legitimate purposes. They help prevent fraud, confirm entitlement, establish medical necessity and protect public resources.

However, poorly designed administrative processes can create delays and confusion for patients, particularly during emergencies.

Patients and families may not know which hospital to approach, which documents to carry, which treatments are covered or whom to contact when a request is delayed.

A person facing a medical emergency should not have to navigate an unnecessarily complicated administrative system before receiving appropriate urgent care.

The goal should not be to eliminate all checks. It should be to make them proportionate, transparent and efficient.

Practical improvements include clearly communicated benefit rules, trained help desks, timely authorisation, accessible grievance mechanisms and escalation procedures for urgent cases.

Hospitals also need clear communication with patients about what is covered and what, if anything, they may be expected to pay.

Transparency before treatment can prevent confusion and reduce the risk of unexpected financial demands.

9. The economic consequences of inadequate access

When insurance fails to translate into timely, appropriate care, the consequences extend beyond the individual patient.

For households: Delayed treatment can increase medical expenses, reduce earnings, exhaust savings and create debt.

For employers: Untreated illness can contribute to absenteeism, reduced productivity and longer periods away from work.

For hospitals: Unclear reimbursement arrangements, delayed payments and administrative disputes can affect cash flow and the capacity to maintain services.

For insurers and public purchasers: Poorly coordinated care can contribute to avoidable complications, repeated admissions and inefficient use of funds.

For the economy: Preventable illness and disability can reduce workforce participation and place additional pressure on public and private resources.

The economic objective should therefore be to ensure that healthcare financing produces effective treatment, not merely financial transactions.

A well-designed insurance system should help people obtain care earlier, receive appropriate treatment and avoid preventable complications. It should also encourage efficient purchasing and responsible use of limited healthcare resources.

10. What needs to change? From insurance coverage to healthcare assurance

India does not need to choose between expanding health insurance and strengthening healthcare delivery. Both are necessary.

The next phase of reform should focus on the following priorities.

A. Measure access, not just enrolment

Public reporting should go beyond the number of insurance cards issued. It should also measure whether patients can find an appropriate provider, how long they wait, whether treatment is completed and what costs remain with the household.

B. Strengthen healthcare infrastructure in underserved regions

District hospitals, community health centres and primary healthcare facilities need appropriate staffing, essential medicines, diagnostics and referral systems. Specialist services should be developed according to local disease burden and realistic demand.

C. Improve hospital participation and payment systems

Public purchasers should periodically review treatment-package costs, settle valid claims predictably and understand why hospitals withdraw from or limit participation in schemes.

At the same time, participating hospitals should be held accountable for appropriate billing, treatment quality and compliance with scheme requirements.

D. Close important coverage gaps

Policymakers and insurers should evaluate how essential outpatient consultations, medicines, diagnostic services and post-hospitalisation care can be made more affordable, especially for patients with chronic diseases.

The appropriate benefit design will depend on fiscal capacity, clinical need and the effectiveness of different purchasing models.

E. Establish stronger quality assurance

Hospital empanelment should be supported by meaningful clinical standards, periodic assessments, patient feedback and transparent mechanisms for addressing poor performance.

F. Make patient navigation simpler

Beneficiaries need accessible information about eligibility, covered treatments, participating hospitals, exclusions and grievance procedures. Support should be available in local languages and through channels accessible to people with limited digital literacy.

G. Make the patient journey the unit of accountability

Healthcare services should be assessed from the patient's first consultation through diagnosis, treatment, discharge and follow-up.

This approach can reveal gaps that are missed when each stage is managed by a separate provider or financing arrangement.

The ultimate test is whether the patient receives the necessary care safely, on time and at an affordable total cost.

Conclusion: India must move from insured lives to protected lives

Health insurance is an essential component of a modern healthcare system. Public schemes and private policies can reduce the financial burden of illness, expand access to hospital treatment and provide greater security to households.

But insurance is a means to an end—not the end itself.

A valid insurance card cannot compensate for the absence of a specialist, an unavailable hospital bed, an unaffordable journey, an uncovered medicine or poor clinical quality.

India's next healthcare challenge is therefore to connect financing with actual service delivery. This requires investment in healthcare infrastructure, effective public purchasing, responsible private participation, better outpatient protection, reliable claims administration and rigorous quality assurance.

The country must measure success not only by how many people are insured, but by how many can obtain the care they need when they need it.

The real measure of universal healthcare is not whether a person possesses an insurance card. It is whether that person can access timely, safe, effective and affordable treatment without being pushed into financial hardship.

India's healthcare system will move closer to that goal when insurance becomes more than a promise of payment—and becomes a dependable pathway to quality care.


The Economics of Healthcare in India: Balancing Affordability, Accessibility and Profitability

 

The Economics of Healthcare in India: Balancing Affordability, Accessibility and Profitability

Temasek's Manipal deal: Why PE firms are keen to get a foothold in India's healthcare space - BusinessToday


India stands at a defining moment in the evolution of its healthcare economy. With a large population, a rising burden of chronic diseases, rapid urbanisation, expanding health insurance coverage and increasing investment in medical technology, the country presents both a significant healthcare opportunity and a complex economic challenge.

Healthcare in India is no longer simply a matter of hospitals, doctors and medicines. It is an interconnected economic system involving public expenditure, private investment, insurance, pharmaceutical manufacturing, medical devices, digital health and household finances.

The central question is no longer just how India can deliver more healthcare. It is how the country can deliver better health outcomes at an affordable cost while building a financially sustainable healthcare system.

For policymakers, hospital leaders, healthcare entrepreneurs, investors and public health professionals, understanding this balance is essential to understanding the future of India's healthcare industry.

1. Understanding the Indian healthcare economy

Healthcare economics examines how limited resources are allocated to meet the health needs of a population. In India, this challenge is particularly important because the demand for healthcare is enormous, while the financial capacity to pay for it remains unevenly distributed.

The Indian healthcare ecosystem broadly consists of five interconnected segments:

  • Public healthcare: Government-funded primary health centres, community health centres, district hospitals and tertiary institutions.

  • Private healthcare providers: Corporate hospital chains, independent hospitals, nursing homes, clinics and diagnostic centres.

  • Pharmaceuticals and medical technology: Drug manufacturers, medical device companies, laboratories and technology providers.

  • Health financing: Government health schemes, private health insurance, employer-sponsored coverage and direct household payments.

  • Digital healthcare: Telemedicine, electronic health records, health technology platforms and AI-enabled clinical and administrative solutions.

These segments do not operate independently. Public investment in primary care can reduce avoidable hospital admissions. Insurance can improve access to treatment but may also increase costs if incentives are poorly designed. Digital systems can improve efficiency, provided they are integrated into clinical workflows and accessible to patients.

The real strength of India's healthcare economy will depend on how effectively these components work together.

2. The size of the opportunity—and the affordability challenge

India's healthcare market has substantial long-term growth potential. Rising incomes, an ageing population, increasing awareness of preventive care, a growing burden of non-communicable diseases and demand for advanced treatments are expanding the need for healthcare services.

However, industry growth and improved public health are not necessarily the same thing.

A healthcare market can grow because more people receive timely preventive treatment, but it can also grow because treatment becomes more expensive or patients require care for conditions that could have been prevented.

This distinction matters.

From a business perspective, rising demand creates opportunities for hospital expansion, specialised clinical services, diagnostics, insurance products and pharmaceutical innovation. From a public health perspective, the objective is to improve health outcomes, reduce avoidable illness and ensure that the cost of care does not push families into financial distress.

The most valuable healthcare businesses will be those that combine clinical quality, operational efficiency and affordability—not merely those that maximise patient volumes.

3. India's healthcare spending: What do the numbers reveal?

The latest official National Health Accounts estimates, released in May 2026 for the financial year 2022–23, provide an important picture of India's healthcare financing structure.

Press Information Bureau

+1

INDIA'S HEALTHCARE ECONOMY • FY 2022–23

3.83%

Total health expenditure as a share of GDP in FY 2021–22

43.7%

Government share of total health expenditure in FY 2022–23

43.4%

Out-of-pocket share of total health expenditure in FY 2022–23

₹1.4 lakh cr

Government spending on primary healthcare in FY 2022–23

Sources: Ministry of Health and Family Welfare, National Health Accounts estimates. The GDP figure shown is for FY 2021–22, not FY 2022–23.

Press Information Bureau

+1

One of the most important indicators is out-of-pocket expenditure (OOPE)—the amount households pay directly for healthcare instead of having the cost covered by government funding, insurance or other financing arrangements.

India's OOPE share declined from 64.2% in 2013–14 to 43.4% in 2022–23. This represents meaningful progress, although direct household spending remains a substantial component of healthcare financing.

Press Information Bureau

+1

The economic implications are significant.

When households must pay substantial amounts for hospitalisation, medicines, diagnostics or long-term treatment, they may reduce essential consumption, borrow money, deplete savings or delay care. These consequences affect not only individual families but also workforce participation, productivity and economic security.

Reducing OOPE is therefore more than a health policy objective. It is an investment in household financial resilience.

4. Public versus private healthcare: Partners, not opponents

India's healthcare debate is often framed as a contest between public hospitals and private providers. This is an incomplete way to understand the economics.

Public healthcare is essential for equitable access, disease surveillance, immunisation, maternal and child health, preventive services and the treatment of people who cannot afford market-priced care.

Private healthcare contributes investment capital, specialised clinical services, technology adoption, operational capacity and additional treatment options. Private providers can also expand capacity where public facilities are insufficient, provided services remain affordable and appropriately regulated.

The real challenge is to create a system in which both sectors strengthen overall health outcomes.

Aspirational Blocks Programme

The public healthcare model

Its economic value lies in providing essential services, addressing market failures and improving population health. Preventive care, early diagnosis and reliable primary healthcare can avert more expensive complications later.

Healthcare | Caught in an ill wind - India Today


The private healthcare model

Its economic strengths include investment, specialisation, service innovation and operational flexibility. Its sustainability, however, depends on responsible pricing, quality outcomes, efficient capacity utilisation and patient trust.

A well-designed public-private partnership can support diagnostics, emergency care, specialist referrals and hospital capacity in underserved regions. But such partnerships require transparent contracts, measurable outcomes and clear accountability for public funds.

The objective should not be to make every healthcare service free or to maximise private-sector profits. It should be to ensure that patients receive appropriate care without unnecessary financial hardship.

5. Health insurance: The missing link between demand and financial protection

Health insurance plays a crucial role in distributing healthcare costs across a larger pool of people. Rather than one household bearing the entire cost of a major illness, a well-functioning insurance system spreads risk across many contributors.

Government-supported schemes such as Ayushman Bharat PM-JAY aim to improve access to eligible hospital treatment. Private and employer-sponsored insurance also contribute to healthcare financing.

Yet insurance coverage alone does not guarantee comprehensive financial protection.

Several challenges remain:

  • Coverage gaps: Policies may exclude certain treatments, impose limits or fail to cover outpatient consultations and routine medicines adequately.

  • Provider pricing: Weak purchasing arrangements can lead to inconsistent pricing and incentives for unnecessary services.

  • Claims administration: Delays, disputes and complex documentation can affect both hospitals and patients.

  • Uneven access: Insurance is less effective when nearby facilities lack the staff, equipment or capacity to deliver appropriate treatment.

From a healthcare business perspective, the next stage of insurance development should focus on value-based purchasing, preventive care, transparent provider networks and better management of chronic conditions.

For insurers, the goal should be to manage risk intelligently rather than simply restrict claims. For hospitals, it should be to deliver appropriate clinical outcomes at predictable costs. For patients, the benefit should be meaningful protection against financial shocks.

6. Hospital economics: Revenue is not the same as profitability

The expansion of India's private hospital sector has attracted significant investor interest. However, healthcare is a capital-intensive business, and high demand does not automatically translate into sustainable profits.

A hospital must balance clinical excellence with financial discipline.

Its performance depends on several interrelated factors:

  • Bed occupancy: Whether available beds are used efficiently without compromising appropriate admissions or patient safety.

  • Average revenue per occupied bed: The revenue generated from inpatient services, interpreted alongside case complexity and payer mix.

  • Length of stay: The duration of admission, balanced against clinical necessity and safe discharge.

  • Operating costs: Staffing, medicines, consumables, equipment maintenance, utilities and outsourced services.

  • Capital expenditure: Investment in buildings, intensive care units, imaging equipment and specialised infrastructure.

  • Receivables and cash flow: The time required for insurers, government schemes and other payers to settle bills.

  • Clinical quality: Complications, readmissions, infection rates, patient experience and treatment outcomes.

Consider a simplified illustration.

ILLUSTRATIVE HOSPITAL UNIT ECONOMICS

A 100-bed hospital

Assumptions: 70% average occupancy and 30 days in a month.

Available bed-days per month

3,000

Occupied bed-days

2,100

Average inpatient revenue per occupied bed-day

₹10,000

Illustrative monthly inpatient revenue

₹2.1 crore

Calculation: 2,100 occupied bed-days × ₹10,000. This excludes outpatient and other revenue, and is not a forecast or a measure of profit.

The hospital's actual financial performance will depend on its operating costs, payer mix, case severity, billing practices, capital financing and other revenue streams.

A hospital can report impressive revenue while generating weak cash flow because of delayed reimbursements, high debt servicing or inefficient operations. Conversely, a hospital with disciplined costs and strong clinical outcomes may achieve sustainable returns without relying on excessive treatment volumes.

This is why healthcare leaders must evaluate revenue, operating margins, cash conversion, capital efficiency and patient outcomes together.

7. The economics of preventive healthcare

One of the most underappreciated opportunities in India's healthcare system is the economic value of prevention.

Non-communicable diseases such as diabetes, cardiovascular disease, cancer and chronic respiratory conditions create long-term costs for patients, employers, insurers and governments.

When conditions are detected late, treatment can require complex interventions, prolonged hospitalisation and ongoing rehabilitation. Earlier diagnosis and effective disease management can sometimes prevent these costs or reduce their severity.

Preventive healthcare creates value through:

  1. Screening and early detection.

  2. Improved access to primary care.

  3. Better adherence to prescribed treatment.

  4. Lifestyle interventions and patient education.

  5. Regular monitoring of chronic diseases.

  6. Timely referral to specialist services.

The financial benefits depend on the condition, intervention, population and quality of implementation; not every screening programme produces net savings.

Nevertheless, prevention should be assessed through a broader economic lens that includes healthy life-years, reduced disability, productivity and financial protection—not only immediate hospital expenditure.

For healthcare businesses, this creates opportunities in chronic disease management, diagnostics, home-based care, workplace wellness and longitudinal patient support. The strongest models will demonstrate measurable benefits rather than simply increasing the number of tests or consultations sold.

8. Medical tourism and India's competitive advantage

Medical Tourism Revenues Grow Despite Conflicts - Rediff.com Business

Add to Favorites

India has the potential to strengthen its position as a destination for international patients seeking specialised medical treatment. Its advantages include a large pool of medical professionals, established centres of clinical expertise, pharmaceutical capabilities and comparatively competitive treatment costs for selected procedures.

Potential growth areas include cardiac care, orthopaedics, oncology, organ transplantation where legally permitted, fertility services and rehabilitation.

However, medical tourism should not be viewed solely as an opportunity to generate foreign exchange. Long-term competitiveness also requires strong accreditation, consistent clinical outcomes, transparent pricing, continuity of care after discharge and safeguards for domestic patients.

A sustainable medical tourism strategy should create economic value while strengthening India's broader healthcare capabilities.

9. Digital health and artificial intelligence: Can technology reduce costs?

Digital healthcare is often presented as a solution to inefficiency, but technology creates economic value only when it solves a genuine operational or clinical problem.

India's digital health ecosystem offers opportunities in telemedicine, electronic health records, interoperable health information, remote monitoring, diagnostic support and administrative automation.

Consider a few practical applications:

TechnologyPotential economic benefit
TelemedicineReduces avoidable travel and improves access to consultations
AI-assisted diagnosticsSupports clinical decision-making and workflow efficiency
Digital hospital managementImproves scheduling, resource utilisation and billing processes
Remote chronic-care monitoringEnables earlier intervention for selected patients
Electronic health recordsReduces fragmented information and unnecessary duplication

The benefits are not automatic. Poor implementation can create additional administrative work, privacy risks, inaccurate outputs and new costs.

Healthcare organisations should assess technology investments using measurable indicators such as cost per consultation, diagnostic turnaround time, staff productivity, readmission rates, patient satisfaction and clinical safety.

The strategic question is not whether a hospital uses artificial intelligence. It is whether that technology makes care safer, more accessible or more economically efficient.

10. The economics of healthcare beyond metropolitan India

India's healthcare opportunity is not confined to major cities.

Smaller cities, district headquarters and semi-urban regions need stronger diagnostic networks, specialist access, emergency services, maternity care and dependable secondary hospitals.

Expansion into these markets, however, requires a different business model from that used in large metropolitan centres.

Lower purchasing power, shortages of specialist staff, referral challenges and limited insurance penetration can constrain profitability. At the same time, lower real estate costs and unmet demand can create opportunities for appropriately designed facilities.

Successful regional healthcare models may combine:

  • Compact hospitals focused on essential specialities.

  • Diagnostic hubs linked to smaller collection centres.

  • Teleconsultation supported by local clinical teams.

  • Referral partnerships with tertiary hospitals.

  • Reliable emergency transport and stabilisation services.

  • Affordable financing and transparent treatment packages.

Investors should assess local disease burden, household affordability, referral flows, workforce availability and payer arrangements before committing capital.

The objective should be to develop services around local healthcare needs rather than simply replicate metropolitan hospital infrastructure.

11. The major challenges facing India's healthcare economy

Despite considerable opportunities, several structural issues continue to influence the economics of Indian healthcare.

1. High direct household spending

Even as OOPE has declined, the latest available official estimates for 2022–23 show that it accounted for 43.4% of total health expenditure. Medicines, outpatient care and uncovered treatments remain important considerations.

Press Information Bureau

2. Unequal distribution of healthcare resources

Differences in infrastructure, specialist availability and service quality across states and districts affect access and outcomes.

3. Public financing constraints

Government spending has increased substantially, but competing demands on public budgets make sustained investment, efficient purchasing and effective implementation essential.

Press Information Bureau

4. Fragmented healthcare delivery

Weak coordination between primary, secondary and tertiary care can lead to delayed diagnosis, duplicated investigations and avoidable hospital admissions.

5. Balancing commercial incentives and patient welfare

Healthcare providers need financial sustainability, but incentives based exclusively on procedure volumes or revenue can conflict with appropriate care. Transparent pricing, clinical governance and outcome measurement are essential.

These challenges are interconnected. Increasing insurance coverage without sufficient provider capacity may not improve access. Expanding hospital infrastructure without adequate staffing may create underutilised assets. Investing in advanced technology without strengthening primary care may direct resources towards expensive interventions while basic needs remain unmet.

India therefore needs a coordinated approach to financing, service delivery, workforce development and regulation.

12. What should India's healthcare strategy prioritise?

A stronger healthcare economy requires decisions that connect public health objectives with sound business and financial principles.

The following priorities deserve particular attention.

First, strengthen primary healthcare. Accessible primary care can improve early diagnosis, continuity of treatment and referral efficiency.

Second, increase the effectiveness of public spending. Budgets should be linked to measurable improvements in service availability, quality and health outcomes.

Third, improve financial protection. Insurance design, public provision of essential services and transparent treatment pricing should work together to reduce catastrophic household expenditure.

Fourth, reward value rather than volume. Where practical, provider payments should encourage appropriate treatment, quality outcomes and efficient resource utilisation instead of unnecessary interventions.

Fifth, build healthcare capacity beyond metropolitan centres. Infrastructure investments should be supported by adequate staffing, referral networks and financially viable operating models.

Sixth, develop a stronger health workforce. Doctors, nurses, allied health professionals, technicians and hospital administrators are essential to converting investment into actual healthcare delivery.

Seventh, invest in evidence-based innovation. Digital health, medical devices and AI should be evaluated for effectiveness, safety, affordability and scalability.

Finally, improve transparency. Better data on costs, outcomes, waiting times, service utilisation and financial performance can help policymakers, providers and patients make more informed decisions.

13. The future of India's healthcare business

Over the coming decade, India's healthcare industry will likely be shaped by the interaction of five major forces: demographic change, chronic disease, insurance expansion, technological innovation and investment in healthcare infrastructure.

For investors, opportunities will extend beyond large multispecialty hospitals to diagnostics, affordable specialty care, home healthcare, medical technology, chronic disease management and regional healthcare networks.

For hospital administrators, operational excellence and clinical quality will become increasingly important to financial sustainability.

For insurers, the challenge will be to provide meaningful protection while managing medical inflation and encouraging appropriate utilisation.

For policymakers, the priority will be to convert increased healthcare spending into equitable access, improved outcomes and reduced financial vulnerability.

The most important business distinction will be between growth that merely increases healthcare expenditure and growth that produces demonstrably better health.

A successful healthcare economy must support innovation and investment without losing sight of the patient. Commercial returns are necessary to sustain many healthcare services, but the legitimacy of the system ultimately depends on whether people can obtain appropriate care when they need it.

Conclusion: India's healthcare economy must grow in value, not just in size

India has made progress in expanding healthcare access, increasing public health expenditure and reducing the proportion of healthcare spending borne directly by households. Yet affordability, uneven access, fragmented service delivery and the need for sustainable financing remain significant challenges.